Replies to post #586205 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

I think it cleans up a future concern.

Part of approval consideration includes ability to meet demand. By differentiating how regulators handle companies that manufacture cell therapies for individual batches (there are other rules as well), draconian shortage comparisons with non-individual based treatments and measures can be avoided.